Cerenome (PSTV) Profit After Tax (2011 - 2026)
Plus Therapeutics (PSTV) posted quarterly Profit After Tax of -$6.9 million for Q1 2026, up 60.08% year-over-year from -$4.3 million in Q1 2025, and down 21.29% quarter-over-quarter from -$5.7 million in Q4 2025.
Cerenome (PSTV) Profit After Tax (2011 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has reported Profit After Tax for 16 consecutive years, with -$6.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Profit After Tax rose 60.08% year-over-year to -$6.9 million; the TTM figure through Mar 2026 stood at -$11.9 million (up 55.95% YoY), while the FY2025 annual figure was -$22.4 million, down 72.6% from the prior year.
- Profit After Tax fell to -$6.9 million in Q1 2026 per PSTV's latest filing, from -$5.7 million in the prior quarter.
- Across five years, Profit After Tax topped out at $5.2 million in Q2 2025 and bottomed at -$17.4 million in Q1 2025.
- Historically, Profit After Tax has averaged -$4.5 million across 5 years, with a median of -$4.1 million in 2022.
- On a YoY basis, Profit After Tax climbed as much as 275.2% in 2025 and fell as far as 433.61% in 2025.
- Plus Therapeutics' Profit After Tax stood at -$5.7 million in 2022, then soared by 32.66% to -$3.8 million in 2023, then retreated by 2.44% to -$3.9 million in 2024, then tumbled by 46.73% to -$5.7 million in 2025, then fell by 21.29% to -$6.9 million in 2026.
- Business Quant data shows PSTV's Profit After Tax at -$6.9 million in Q1 2026, -$5.7 million in Q4 2025, and -$4.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 472.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -16.62 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - | -9.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.95 Mn |
| Dec 31, 2025 | -5.73 Mn |
| Sep 30, 2025 | -4.42 Mn |
| Jun 30, 2025 | 5.15 Mn |
| Mar 31, 2025 | -17.40 Mn |
| Dec 31, 2024 | -3.90 Mn |
| Sep 30, 2024 | -2.87 Mn |
| Jun 30, 2024 | -2.94 Mn |
| Mar 31, 2024 | -3.26 Mn |
| Dec 31, 2023 | -3.81 Mn |
| Sep 30, 2023 | -3.22 Mn |
| Jun 30, 2023 | -1.48 Mn |
| Mar 31, 2023 | -4.81 Mn |
| Dec 31, 2022 | -5.66 Mn |
| Sep 30, 2022 | -5.22 Mn |
| Jun 30, 2022 | -5.28 Mn |
| Mar 31, 2022 | -4.12 Mn |
| Dec 31, 2021 | -4.16 Mn |
| Sep 30, 2021 | -3.72 Mn |
| Jun 30, 2021 | -2.80 Mn |